We already supply, project manage and support over 50% of the top twenty largest pharmaceutical names and manufacturers of equipment used during the production of sterile medicinal product and medical devices while providing similar services to other sectors where bio-decontamination is critical to ensure the safety and efficacy of the process is assured.
Whether designing manufacturing facilities, building bespoke equipment or managing quality assurance of pharmaceutical production our product is the most effective method of bio-decontamination efficacy in clean room settings and sterile environments where high levels of sterility are required.
Enzyme Indicator Technology
In addition to Enzyme Indicator technology we provide expert consultancy services for organisations requiring bio-decontamination validation of facilities, equipment, processes offering validation lifecycle support for a range of unique needs and requirements. We’re working in partnership with a growing number of Hospitals involved in pharmacy compounding and the development of bespoke aseptic suites.
Our advanced Enzyme Indicator technology can be effectively applied in any industry sector where gaseous bio-decontamination is used throughout the validation process. Enzyme Indicators generate real-time quantifiable results and data in seconds, compared to the traditional validation tool with a 7 day incubation period, generating ‘challenge area’ specific data reducing cost, saving time and improving efficiency.
Industry Focus Group
We’re working alongside many of the biggest pharmaceutical companies creating a standardised approach to H₂O₂ and other gaseous bio-decontamination validation. Our groups’ membership includes AstraZeneca, Baxter, Bayer, Novo Nordisk, Sanofi, Pfizer and Roche.